2013
DOI: 10.1152/ajpendo.00446.2012
|View full text |Cite
|
Sign up to set email alerts
|

Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose

Abstract: Burmeister MA, Ayala J, Drucker DJ, Ayala JE. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose. Am J Physiol Endocrinol Metab 304: E677-E685, 2013. First published January 22, 2013 doi:10.1152/ajpendo.00446.2012.-Glucagon-like peptide-1 (GLP-1) suppresses food intake via activation of a central (i.e., brain) GLP-1 receptor (GLP-1R). Central AMP-activated protein kinase (AMPK) is a nutrient-sensitive regulator… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
56
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(60 citation statements)
references
References 65 publications
4
56
0
Order By: Relevance
“…Even studies exclusively utilizing fructosesweetened drinks to show this association have been contested, as fructose-sweetened drinks provide additional calories, which alone could explain the higher rates of obesity and metabolic complications. In fact, some studies suggest that fructose-increased caloric intake, mediated via leptin resistance (45) and antagonism of GLP-1R action in the brain (46), leads to increased adipogenic potential (47) and visceral adipose tissue inflammation (48). Our model controlled for additional calories ingested from sugarsweetened drinks by comparing the effects of fructose to those of isocaloric glucose, and while both monosaccharides resulted in higher total caloric intake, there was no difference in energy intake between the 2 sugar-supplemented groups.…”
Section: Animals and Dietsmentioning
confidence: 99%
“…Even studies exclusively utilizing fructosesweetened drinks to show this association have been contested, as fructose-sweetened drinks provide additional calories, which alone could explain the higher rates of obesity and metabolic complications. In fact, some studies suggest that fructose-increased caloric intake, mediated via leptin resistance (45) and antagonism of GLP-1R action in the brain (46), leads to increased adipogenic potential (47) and visceral adipose tissue inflammation (48). Our model controlled for additional calories ingested from sugarsweetened drinks by comparing the effects of fructose to those of isocaloric glucose, and while both monosaccharides resulted in higher total caloric intake, there was no difference in energy intake between the 2 sugar-supplemented groups.…”
Section: Animals and Dietsmentioning
confidence: 99%
“…Particularly, fructose and sucrose promote higher densities than glucose. Recently, it was shown on mice that fructose can stimulate adenosine monophosphate-activated protein kinase (29,30). In turn, adenosine monophosphateactivated protein kinase can activate peroxisome proliferator-activated receptor-γ coactivator-1α involved in mitochondrial biogenesis by coactivating corresponding transcriptional factors, such as nuclear respiratory factor 1, nuclear respiratory factor 2, peroxisome proliferatoractivated receptor gamma, and others (31).…”
Section: Discussionmentioning
confidence: 99%
“…Under physiological conditions, insulin secretion may depend on the GLP-1 receptor (GLP-1R)-mediated aerobic metabolization of glucose through glycolysis and the subsequent raising in cytosolic ATP levels (108). As a consequence, the hyperpolarizing K ATP channels close, β-cell membrane depolarization occurs, allowing calcium influx through voltage-dependent calcium channels (VDCC) occurs and calcium-dependent insulin exocytosis is potentiated (105, 106, 108) (Figure 2). Alternatively, insulin secretion may be stimulated by intracellular signaling cascades involving, e.g., cAMP or its downstream target Epac (exchange protein activated by cAMP), PKA, AMPK, protein kinase C (PKC), and MAPK, as it has been described for GLP-1-mediated stimulation of glucose-dependent insulin release (108).…”
Section: Introductionmentioning
confidence: 99%